BioSpace News Archive

iTeos Therapeutics SA today announced that management will participate in two upcoming conferences in November.

Trial Results Anticipated First Half 2019

Retrophin, Inc. today announced that Stephen Aselage, chief executive officer, will present at the Jefferies 2018 London Healthcare Conference in London, UK on Wednesday, November 14, 2018 at 4:40 p.m. GMT (11:40 a.m. ET).

Commercial team preparing for potential gene therapy launches

The Company Announced Its Decision To End Its Long-Term Agreement To Provide The Rotavirus Vaccinee To Children In West Africa In Favor Of Shifting To China Where They Could Increase Profit Margins

GeoVax Labs, Inc. announced its financial results for the quarter ended September 30, 2018, and provided an update on its research and development programs.

An ovarian cancer treatment co-developed by Germany’s Merck KGaA and Pfizer failed to meet endpoints for overall survival and progression-free survival in a Phase III trial.

Tesaro, located in Waltham, Mass., is rumored to be up for sale. The rumors caused shares to rocket as much as 39 percent on Friday, but it’s not the first time rumors have floated that the company might be on the auction block.

Boston Scientific’s restructuring will take place over a three-year period. The company expects it overall employee base to remain relatively unchanged when it is complete, although some losses are expected.

When drug trials are mentioned, mental dots are connected to large hospitals first, with names like the Cleveland Clinic, the Mayo Clinic, or New York Presbyterian Hospital coming to mind. Often overlooked, however, are smaller regional hospitals, important players in the total research picture that are rarely acknowledged as contributors in the information game.